Pain Relief Demand The large and growing market for non-drug pain management, with chronic pain affecting over 100 million Americans, presents a significant opportunity for Oska Pulse to expand direct-to-consumer outreach and healthcare partnerships seeking drug-free relief solutions.

Clinical Validation Oska Pulse is backed by a randomized, double-blind placebo study and has demonstrated pain reduction and mobility improvements, which can be leveraged in conversations with clinics, physical therapists, and HR wellness programs emphasizing evidence-based, non-pharmacologic options.

Accessibility Advantage The device is non-invasive, portable, lightweight, and has no known side effects, enabling easy adoption across consumer channels, physical therapy practices, sports teams, and corporate wellness programs seeking convenient pain-management tools.

Strategic Partnerships Historical partnerships and international expansion, including launches in India and collaborations with healthcare organizations, suggest a continued path for distribution partnerships, channel intermediaries, and B2B licensing opportunities.

Financial Scale With revenue in the low-to-mid single digits and a funding base of 5.5 million, there is room for scaled sales efforts targeting mid-market organizations, clinics, and e-commerce channels, supported by strong messaging around cost-effective, medication-free relief.